期刊
BIOMOLECULES
卷 13, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/biom13111575
关键词
8-hydroxydaidzein; apoptosis; CDK6; caspase-7; acute myeloid leukemia
The compound 8-hydroxydaidzein (8-OHD) has been found to inhibit cell proliferation and induce apoptosis in acute myeloid leukemia (AML) cells. It downregulates the expression of AML-associated genes and interacts with key proteins involved in cell proliferation. Furthermore, a synergistic effect is observed when 8-OHD is used in combination with cytarabine (Ara-C), a standard chemotherapy drug for AML.
Background: 8-hydroxydaidzein (8-OHD) is a compound derived from daidzein, known for its anti-inflammatory and anti-proliferative properties in K562 human chronic myeloid leukemia (CML) cells. However, its effects on acute myeloid leukemia (AML) cells have not been fully understood. Method: To investigate its potential anti-AML mechanism, we employed an integrated in vitro-in silico approach. Results: Our findings demonstrate that 8-OHD suppresses the expression of CDK6 and CCND2 proteins and induces cell apoptosis in U-937 cells by activating Caspase-7 and cleaving PARP-1. Microarray analysis revealed that 8-OHD downregulates differentially expressed genes (DEGs) associated with rRNA processing and ribosome biogenesis pathways. Moreover, AML-target genes, including CCND2, MYC, NPM1, FLT3, and TERT, were downregulated by 8-OHD. Additionally, molecular docking software predicted that 8-OHD has the potential to interact with CDK6, FLT3, and TERT proteins, thereby reducing their activity and inhibiting cell proliferation. Notably, we discovered a synergic pharmacological interaction between 8-OHD and cytarabine (Ara-C). Conclusions: Overall, this study provides insights into the therapeutic applications of 8-OHD in treating AML and elucidates its underlying mechanisms of action.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据